Breaking News on Global Pharmaceutical Technology & Manufacturing


AZ for $100bn? Pfizer could buy Azerbaijan and keep the change

22-Apr-2014 - With Pfizer rumoured to be on the brink of a mega-merger with AstraZeneca, brings you an interactive view of what £60bn ($101bn) could get.

Albemarle to sell ibuprofen business to SI Group

17-Apr-2014 - Albemarle has agreed to sell its ibuprofen business to US chemical intermediates firm SI Group in a deal that will also see it divest the anaesthetic agent, propofol.


Sun Pharma's $3.2bn Ranbaxy acq: 'Compliance first, synergies later'

07-Apr-2014 - Regulatory compliance will be the number one focus for Sun Pharma, the company says, following its $3.2bn (€2.3bn) takeover of Indian generics firm Ranbaxy.

Lupin: Mexican buy a bridgehead to generics and API growth

01-Apr-2014 - Lupin has bought Mexican eye drugmaker Grin in a deal that gives it a “bridgehead” to grow its API and generics business in the region.

Hospira edges closer to completion of Orchid API deal in India

18-Mar-2014 - The Board of Directors at Indian firm Orchid has approved the sale of its API business to Hospira, bringing the acquisition a step closer to completion.

People on the Move

People on the Move: Pharma movers and shakers

17-Mar-2014 - Twin changes at AstraZeneca's MedImmune kick off this week's gallery, as well as jobs news from Europe


Actavis to acquire Forest labs in $25bn takeover

18-Feb-2014 - Actavis has confirmed it will acquire Forest Laboratories in a deal worth up to $25bn (€18bn) following rumours last night.

Targeted drug delivery driving partnerships, says expert

06-Feb-2014 - An increased trend in dealmaking for targeted drug delivery last year will continue to drive partnerships in 2014, according to a pharmaceutical partnering expert.

Lupin buys Dutch delivery tech firm for injectables entry

03-Feb-2014 - Lupin Ltd has bought Dutch delivery technology company Nanomi BV in a deal that moves the Indian generics firm into the complex injectables space.

Hospira intent on growing Indian ops as EU market beckons

23-Jan-2014 - Increased in-house API production and manufacturing in India will lower the costs of Hospira’s injectables, the firm says, as it looks past current remediation efforts.

Complex generics will boost speciality biz, Teva says

16-Jan-2014 - Complex generics will represent over 50% of Teva’s generic market by 2017, the firm says, but investments in delivery technology will have positive implications across the full business.

Alnylam buys Merck's siRNA tech biz as Sanofi inks $700m alliance

13-Jan-2014 - Alnylam has both acquired Merck & Co. subsidiary Sirna therapeutics and extended an alliance with Genzyme in order to advance its small interfering RNA (siRNA) delivery programme.

Philips licenses Aerogen's delivery tech

07-Jan-2014 - Aerogen has licensed its respiratory drug delivery technology to Dutch electronics giant Philips in a deal announced today.

Heparin consolidation: Hepalink to buy SPL for $337m

06-Jan-2014 - Chinese API firm Shenzhen Hepalink has announced plans to buy Scientific Protein Laboratories (SPL) from private equity investor American Capital for $337.5m.

Encap selected to formulate Lipocine's HPAPI oral testosterone

18-Dec-2013 - Encap has collaborated with Lipocine to manufacture its oral testosterone product and says it expects continued growth in demand for HPAPI formulation services.


Over-capacity and patent loss sees Pfizer & Merck shutter Puerto Rico plants

25-Nov-2013 - Pfizer says it intends to shutter a manufacturing facility in Puerto Rico just days after Merck & Co. announced it was reducing its footprint on the island.

Aptar launches biologics focused auto-injector

21-Nov-2013 - Aptar Pharma has launched a new auto-injector technology as part of a strategic effort to build its presence in the biopharmaceutical sector.

Granules India to buy Auctus and says Singapore closure is a 'non-event'

04-Nov-2013 - Granules India has outlined plans to buy drug intermediate and API maker Auctus Pharma, set up an actives R&D site and announced its intention to wind up its ‘shell’ operation...

Capsugel and Bend: 'Marriage made in heaven' as first tech transferred

31-Oct-2013 - The acquisition of Bend Research by Capsugel may be “a marriage made in heaven” for customers, the firms say, as the first drug delivery tech is transferred.


Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

23-Oct-2013 - Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit.

MedImmune looks to 'next generation biologics' with $200m ADC investment

15-Oct-2013 - AstraZeneca has become the latest company to invest in antibody-drug conjugate (ADC) technology with the acquisition of Spirogen for $200m (€148m).

Merck & Co.'s New Jersey rejig has some manufacturing implications

09-Oct-2013 - Merck says it is shutting two New Jersey facilities as it moves its headquarters to the Kenilworth site where manufacturing ended last week.

Capsugel to Buy Bend Research to Expand Bioavailability Offering

05-Sep-2013 - Capsugel will buy Bend Research to expand its dosage form solutions (DFS) business in a deal announced earlier today.

GSK in Talks with Several Firms for Romanian Oral Dose Plant

05-Sep-2013 - GlaxoSmithKline is in talks with a number of companies interested in buying its Romanian manufacturing facility that was recently earmarked for closure.

Chiron and Panacea End Injectables JV Amicably, Says Novartis

02-Sep-2013 - Novartis-owned Chiron and Panacea Biotec have amicably dissolved their vaccine joint venture due to strategic regions, according to Novartis.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...